186 related articles for article (PubMed ID: 26821466)
1. [Leukoderma caused by chemicals: mechanisms underlying 4-alkyl/aryl-substituted phenols- and rhododendrol-induced melanocyte loss].
Nishimaki-Mogami T
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2015; (133):13-20. PubMed ID: 26821466
[TBL] [Abstract][Full Text] [Related]
2. A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols.
Ito S; Wakamatsu K
J Dermatol Sci; 2015 Oct; 80(1):18-24. PubMed ID: 26228294
[TBL] [Abstract][Full Text] [Related]
3. Biochemical, cytological, and immunological mechanisms of rhododendrol-induced leukoderma.
Tokura Y; Fujiyama T; Ikeya S; Tatsuno K; Aoshima M; Kasuya A; Ito T
J Dermatol Sci; 2015 Mar; 77(3):146-9. PubMed ID: 25726326
[TBL] [Abstract][Full Text] [Related]
4. A cell-based evaluation of human tyrosinase-mediated metabolic activation of leukoderma-inducing phenolic compounds.
Nishimaki-Mogami T; Ito S; Cui H; Akiyama T; Tamehiro N; Adachi R; Wakamatsu K; Ikarashi Y; Kondo K
J Dermatol Sci; 2022 Nov; 108(2):77-86. PubMed ID: 36567223
[TBL] [Abstract][Full Text] [Related]
5. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma.
Gabe Y; Miyaji A; Kohno M; Hachiya A; Moriwaki S; Baba T
J Dermatol Sci; 2018 Sep; 91(3):311-316. PubMed ID: 30005897
[TBL] [Abstract][Full Text] [Related]
6. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
7. Clinical and epidemiological analysis in 149 cases of rhododendrol-induced leukoderma.
Yoshikawa M; Sumikawa Y; Hida T; Kamiya T; Kase K; Ishii-Osai Y; Kato J; Kan Y; Kamiya S; Sato Y; Yamashita T
J Dermatol; 2017 May; 44(5):582-587. PubMed ID: 27882588
[TBL] [Abstract][Full Text] [Related]
8. Rhododenol-induced leukoderma in a mouse model mimicking Japanese skin.
Abe Y; Okamura K; Kawaguchi M; Hozumi Y; Aoki H; Kunisada T; Ito S; Wakamatsu K; Matsunaga K; Suzuki T
J Dermatol Sci; 2016 Jan; 81(1):35-43. PubMed ID: 26547111
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase-catalyzed oxidation of rhododendrol produces 2-methylchromane-6,7-dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity.
Pigment Cell Melanoma Res; ; . PubMed ID: 24903082
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
